BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT
DEPT OF DEFENSE
About this archived opportunity
The Government is conducting market research to determine whether a commercial solution can be provided to meet requirements for battlefield wound infection prevention and treatment: barrier combination product. This market research may also assist with the further development and/or refinement of the requirements. Objective and Purpose/Scope: DHA�s OPMED WPAC has a requirement to develop, deliver, and field medical products that address battlefield wounds and subsequent bacterial and fungal infections. The Battlefield Wound Infection Prevention and Treatment (BWI P&T) program is using a Family of Systems (FoS) approach that aims to develop multiple medical materiel solutions that are most relevant for use in austere environments where medical products may be limited and evacuation may be prolonged. This RFI seeks responses to the barrier combination component of this FoS only. Although there is an emphasis on use at the point of injury, this capability will likely be used across roles of care spanning the austere battlefield environment to hospital care settings. The barrier combination product is expected to be one of many components of the FoS that will provide novel solutions to the DoD and commercial market with respect to wound care and infection prevention. The barrier combination product must have the following minimum essential characteristics: Please refer to Attachment 3 - Minimum Essential Characteristics (MECS) North American Industry Classification System (NAICS) Code: Unknown RFI Attachments: The following documents are attached to the RFI Attachment 1: Technical Readiness Level (TRL) (Reference Only) Attachment 2: Company & Product Information Attachment 3: Minimum Essential Characteristics (MECS) Response Due Date: Interested parties shall submit the RFI response electronically by 2:00pm Eastern on January 20, 2026, via e-mail to: Please review Attachments 1, 2, and 3 as well as RFI for BWI PT Barrier Attachment for further instructions
Historical details
- Status
- Closed
- Deadline
- January 20, 2026
- First captured
- January 11, 2026
- Publisher reference
- 0f7bf84a247c425b970819fb5a0f4b60
Eligibility: No Set aside used. NONE
This opportunity has closed
BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT
by DEPT OF DEFENSE
Get notified when similar opportunities open
We'll save this search and email you when new opportunities are posted. Free.
Related opportunities
- Microbial Identification System (MIS)DEPT OF DEFENSECloses Apr 2027
- Battlefield Pain Management – AnalgesicDEPT OF DEFENSECloses in 11 days
- Integrated Workforce and Readiness Platform (ARMOR)DEPT OF DEFENSE
- Pharmacy Inpatient Automation Solution - EnterpriseDEPT OF DEFENSECloses in 12 days
- DA01--VA-26-00071371 Memorials Integration Services and InnovationVETERANS AFFAIRS, DEPARTMENT OF
- AN/BLQ-10 Electronic Warfare System Market ResearchDEPT OF DEFENSE